Your browser doesn't support javascript.
loading
Giant malignant insulinoma.
Karavias, Dimitrios; Habeos, Ioannis; Maroulis, Ioannis; Kalogeropoulou, Christina; Tsamandas, Athanasios; Chaveles, Ioannis; Karavias, Dionissios.
Afiliação
  • Karavias D; Department of Surgery, University Hospital of Patras, Rion, Greece.
  • Habeos I; Division of Endocrinology and Diabetes, Department of Internal Medicine, University Hospital of Patras, Rion, Greece.
  • Maroulis I; Department of Surgery, University Hospital of Patras, Rion, Greece.
  • Kalogeropoulou C; Department of Radiology, University Hospital of Patras, Rion, Greece.
  • Tsamandas A; Department of Pathology, University Hospital of Patras, Rion, Greece.
  • Chaveles I; Department of Surgery, University Hospital of Patras, Rion, Greece.
  • Karavias D; Department of Surgery, University Hospital of Patras, Rion, Greece.
Ann Surg Treat Res ; 88(5): 289-93, 2015 May.
Article em En | MEDLINE | ID: mdl-25960993
ABSTRACT
Insulinomas are the most common pancreatic neuroendocrine tumors. Most insulinomas are benign, small, intrapancreatic solid tumors and only large tumors have a tendency for malignancy. Most patients present with symptoms of hypoglycemia that are relieved with the administration of glucose. We herein present the case of a 75-year-old woman who presented with an acute hypoglycemic episode. Subsequent laboratory and radiological studies established the diagnosis of a 17-cm malignant insulinoma, with local invasion to the left kidney, lymph node metastasis, and hepatic metastases. Patient symptoms, diagnostic and imaging work-up and surgical management of both the primary and the metastatic disease are reviewed.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2015 Tipo de documento: Article